Keyphrases
Cisplatin
100%
Drug Resistance
100%
Lung Cancer Brain Metastases
100%
Pemetrexed
50%
Brain Metastases
50%
Etoposide
50%
IC50
50%
Lung Cancer Cells
50%
In Vivo Imaging
25%
Cancer Metastasis
25%
Molecular Mechanism
25%
Human Epidermal Growth Factor Receptor 2 (HER2)
25%
Poor Prognosis
25%
Drug Treatment
25%
Treatment Efficacy
25%
Survival Time
25%
Acquired Resistance
25%
Gefitinib
25%
Tissue Collection
25%
Metastatic Lung Cancer
25%
Vehicle Control
25%
Cancer Drugs
25%
Indocyanine Green
25%
Treatment Group
25%
Inhibition Assay
25%
Quantitative Autoradiography
25%
Tumor Burden
25%
PCR Analysis
25%
Athymic nude Mice
25%
Prolonged Survival
25%
Fluorescent Microscopy
25%
MTT Assay
25%
Neurological Symptoms
25%
E-cadherin
25%
Brain Lesions
25%
Vimentin
25%
Bioluminescence Imaging
25%
Tumor Vasculature
25%
Nontumor
25%
Lung Cancer Patients
25%
Moribund
25%
α-aminoisobutyric Acid
25%
Oregon Green
25%
Gefitinib Resistance
25%
Tumor Region
25%
Targeted Chemotherapy
25%
Cardiac Ventricle
25%
T790M mutation
25%
Pathological Phenomenon
25%
Medicine and Dentistry
Lung Cancer
100%
Brain Metastasis
100%
Drug Resistance
100%
Cisplatin
100%
In Vitro
50%
Cancer Cell
50%
Neoplasm
50%
Pemetrexed
50%
Epidermal Growth Factor Receptor
50%
Gefitinib
50%
IC50
50%
Etoposide
50%
Combination Therapy
25%
Quantitative Reverse Transcription Polymerase Chain Reaction
25%
Drug Therapy
25%
Metastatic Carcinoma
25%
Tissue Banking
25%
Neurologic Disease
25%
Autoradiograph
25%
Fluorescence Microscopy
25%
Carbon 14
25%
Survival Time
25%
Uvomorulin
25%
Radioactive Tracer
25%
Vimentin
25%
MTT Assay
25%
Dying
25%
Tumor Vascularization
25%
Indocyanine Green
25%
Epithelial Mesenchymal Transition
25%
Ventricle (Heart)
25%
2 Amino 2 Methylpropionic Acid
25%
Bioluminescence
25%
Treatment Group
25%
Pharmacology, Toxicology and Pharmaceutical Science
Cisplatin
100%
Lung Cancer
100%
Drug Resistance
100%
Brain Metastasis
100%
Etoposide
50%
Gefitinib
50%
IC50
50%
Neoplasm
50%
Epidermal Growth Factor Receptor
50%
Pemetrexed
50%
Pharmacotherapy
25%
Chemotherapy
25%
Nude Mouse
25%
Autoradiography
25%
Survival Time
25%
Indocyanine Green
25%
Neurologic Disease
25%
Tracer
25%
Uvomorulin
25%
Vimentin
25%
Tumor Vascularization
25%
2 Amino 2 Methylpropionic Acid
25%
Dying
25%
Combination Therapy
25%
Carbon 14
25%
Treatment Group
25%
Neuroscience
Brain Cancer
100%
Cisplatin
100%
Drug Resistance
100%
Etoposide
50%
Gefitinib
50%
Pemetrexed
50%
In Vitro
50%
Epidermal Growth Factor Receptor
50%
In Vivo
25%
Brain Lesion
25%
Vimentin
25%
Uvomorulin
25%
2 Amino 2 Methylpropionic Acid
25%
Autoradiograph
25%
MTT Assay
25%
Bioluminescence
25%
Drug Therapy
25%